Literature DB >> 6328898

Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.

E A Sotaniemi, J H Stengård, H U Saarni, A J Arranto, K Keinänen, T Kerola, S Sutinen.   

Abstract

The role of glucose-6-phosphatase (G6Pase) in postreceptional glucose handling in non-insulin dependent diabetics ( NIDDs ) was in investigated by comparing the enzyme values in diagnostic liver biopsy samples with fasting blood glucose (BG), immunoreactive insulin (IRI) and plasma antipyrine half-life (T/2). The NIDDs , treated with sulphonylureas, had elevated serum aminotransferase and alkaline phosphatase values associated with fatty liver with or without fibrosis. G6Pase activity was reduced in the NIDDs compared with subjects who had undergone gallstone surgery (p less than 0.001), insulin dependent diabetics (p less than 0.001), and age- and sex-matched non-diabetics (p less than 0.001). G6Pase was inversely related to BG and antipyrine T/2, but not to IRI or conventional liver function tests. Therapy with phenobarbital and medroxyprogesterone acetate, known inducers, increased G6Pase activity, shortened antipyrine T/2, reduced BG and did not alter IRI, in four NIDDs . Low liver G6Pase activity in NIDDs may hence be one factor underlying the impaired glycemic control.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328898     DOI: 10.1111/j.0954-6820.1984.tb05014.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  2 in total

1.  Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital.

Authors:  D Argaud; S Halimi; F Catelloni; X M Leverve
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

2.  The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man.

Authors:  J T Lahtela; B Gachalyi; S Eksymä; A Hämäläinen; E A Sotaniemi
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.